SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
GE Healthcare Release: Phase III Results for Investigational Imaging Agent [18F]Flutemetamol Demonstrate Ability to Accurately Detect Beta Amyloid in Living Patients